Ketamine Completed Phase 2 Trials for Major Depressive Disorder (MDD) / Alcohol Use Disorder (AUD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02078817Ketamine in Adolescents With Treatment-Resistant Depression
NCT01558063Ketamine in the Treatment of Depression
NCT03658330Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
NCT01627782A Study of Ketamine in Patients With Treatment-resistant Depression